Navigation Links
BioDiscovery Joins Illumina Connect Bioinformatics Program
Date:11/13/2007

- Integrates Nexus CGH with Illumina's BeadStudio Software -

EL SEGUNDO, Calif., Nov. 13 /PRNewswire/ -- BioDiscovery announced today that it joined Illumina Connect, a bioinformatics program offered by Illumina, Inc., for downstream analysis of microarray data. After collaborating with Illumina, BioDiscovery has successfully created an interface that allows customers using both Illumina's BeadStudio software to seamlessly process their data in BioDiscovery's Nexus CGH advanced copy number analysis software.

Nexus CGH is BioDiscovery's platform-independent solution for the analysis and visualization of multiple samples for identification of regions of chromosomal gain and loss in a population, and performing statistical association studies. Nexus CGH can easily handle large projects including those with thousands of Illumina high-density arrays.

Omoshile Clement, Ph.D., Illumina's Senior Product Manager of Platforms said, "Interest in Illumina Connect has continued to grow because bioinformatics software and service providers recognize the value that Illumina technology brings to their customers. Now that BioDiscovery is a partner, we are excited to work with them to make it easier for customers to access the power of Illumina's genotyping applications for their studies."

"BioDiscovery's drive for platform independence has been realized with Nexus CGH, said Dr. Soheil Shams, President of BioDiscovery. "We are delighted to work with Illumina to create an interface between our products, and to create greater value for scientists and the medical community looking to advance their downstream analysis functionality," said Dr. Shams.

"The user-friendly Nexus interface enables researchers to answer important biological questions without the need for advanced statistical or programming knowledge. With the integration of Illumina's BeadStudio and Nexus CGH, our customers can go from raw data to biological insight in a matter of minutes," said Dr. Shams.

About BioDiscovery, Inc.

BioDiscovery is a leader in the development of microarray advanced bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. Contact us: 310-414-8100 or http://www.biodiscovery.com

CONTACT:

Soheil Shams

President

BioDiscovery, Inc.

310.414.8100 x221

sshams@biodiscovery.com


'/>"/>
SOURCE BioDiscovery, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization
2. Richard Greco Joins Mediware Board
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
5. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
6. Nick Childs Joins Grey New York as Director of Content Development
7. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
8. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
9. NASN Joins Partnership to Fight Chronic Disease
10. AstraZeneca Joins Local Walking Movement
11. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Looking for ... may be at the tips of your toes. Foot massage, whether administered by a ... pure comfort and relaxation. The American Board of Multiple Specialties in Podiatry ...
(Date:2/5/2016)... San Rafael, CA (PRWEB) , ... February 05, 2016 , ... ... partnership with ChildLight Yoga Studio in Dover, NH to direct high-performance kids yoga training. ... on New Hampshire’s seacoast, just one hour from Boston. , ChildLight Yoga Studio founder ...
(Date:2/5/2016)... ... ... Give To Cure today announced that it is working with ... campaign that is crowdfunding clinical trials to help find cures faster for Alzheimer’s Disease. ... device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. , Give ...
(Date:2/5/2016)... ... ... Dr. Justin Scott and Dr. Lydia Muccioli of Pure Dental Health ... need. The event is scheduled to take place on February 27, 2016 from 9am ... care to community members in need. Each patient will be given the opportunity to ...
(Date:2/5/2016)... ... 05, 2016 , ... In sleep, when the defenses of the day are ... of patients with eating disorders is significant self-criticism, and consequently these patients experience this ... regarded as maladaptive means for coping with this unease, but also leads to a ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... -- Wegener Polyangiitis - Pipeline Review, H2 2015 ... - Pipeline Review, H2 2015, provides an overview ... report provides comprehensive information on the therapeutic development ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ...
(Date:2/4/2016)... 4, 2016 Global Immunology Market to ... drive long-term market growth Summary Immune-mediated ... chronic disorders that affect 5–7% of western populations. ... their symptoms and key patient demographics, they are ... pathways and an inappropriate immune response. Generally, disease-modifying ...
(Date:2/4/2016)... Feb. 4, 2016 Mettler-Toledo International Inc. (NYSE: ... 2015.  Provided below are the highlights: , ... compared with the prior year.  Reported sales decreased 3% ... quarter. , Net earnings per diluted share as ... prior- year period.  Adjusted EPS was $4.65, an increase ...
Breaking Medicine Technology: